Early cardioversion of atrial fibrillation facilitated by transesophageal echocardiography: Short-term safety and impact on maintenance of sinus rhythm at 1 year

American Journal of Medicine

Volumn 110, Issue 9, 2001, Pages 694-702

  Weigner, Marilyn J ^a,b   Thomas, Lisa R ^a,b   Patel, Ujjaval ^c   Schwartz, Jeffrey G ^a,b   Burger, Andrew J ^a,b   Douglas, Pamela S ^a,b   Silverman, David I ^c   Manning, Warren J ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UConn Health John Dempsy Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RISK BENEFIT ANALYSIS; SAFETY; SINUS RHYTHM; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PERIODICITY; RECURRENCE; SINOATRIAL NODE; THROMBOEMBOLISM; TIME FACTORS; WARFARIN;

EID: 0035876656     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(01)00716-1     Document Type: Article

References (33)

1. Impact of atrial fibrillation on mortality, stroke, and medical costs
2. Warfarin in the prevention of stroke associated with non-rheumatic atrial fibrillation
3. Stroke prevention in atrial fibrillation. Final results
4. The effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation
5. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications of chronic atrial fibrillation: The Copenhagen AFASAK Study
6. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease
7. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats
8. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation
9. Transesophageal echocardiographic predictors for maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation
10. Amiodarone versus propafenone for conversion of chronic atrial fibrillation: Results of a randomized, controlled study
11. Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilation
12. Cardioversion guided by transesophageal echocardiography: The ACUTE pilot study. A randomized, controlled trial
13. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation: A multicenter study
14. Cardioversion from atrial fibrillation without prolonged anticoagulation with the use of transesophageal echocardiography to exclude the presence of atrial thrombi
15. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short term anticoagulation: Final results of a prospective 4.5-year study
16. Cost-effectiveness of transesophageal echocardiography-guided cardioversion for hospitalized patients with atrial fibrillation
17. Diagnosis of left atrial appendage thrombi by transesophageal echocardiography: Clinical implications and follow-up
18. Are electrophysiological changes induced by longer lasting atrial fibrillation reversible? Observations using the atrial defibrillator
19. Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation
20. Impaired left atrial mechanical function after cardioversion: Relationship to the duration of atrial fibrillation
21. Cardiac performance early after cardioversion from atrial fibrillation
22. Anticoagulation for cardioversion of atrial fibrillation
23. Atrial thrombus resolution after prolonged anticoagulation in patients with atrial fibrillation: A transesophageal echocardiographic study
24. Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation
25. The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation
26. Role of prophylactic anticoagulation for direct cardioversion in patients with atrial fibrillation or atrial flutter
27. Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation
28. Impact of electrical cardioversion of atrial fibrillation on left atrial appendage function and spontaneous echo contrast: Characterization by simultaneous transesophageal echocardiography
29. Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: A retrospective analysis
30. Accuracy of transesophageal echocardiography for identifying left atrial thrombi: A prospective, intraoperative study
31. Thromboembolic risks of left atrial thrombus detected by transesophageal echocardiogram
32. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation
33. Silent cerebral infarction in patients with nonrheumatic atrial fibrillation